3,320
Views
1
CrossRef citations to date
0
Altmetric
Review

Incorporating health inequality impact into economic evaluation in low- and middle-income countries: a systematic review

, &
Pages 17-25 | Received 07 Apr 2021, Accepted 08 Jul 2021, Published online: 21 Jul 2021

References

  • World Health Organisation. World health statistics 2020: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2020.
  • Chao F, You D, Pedersen J, et al. National and regional under-5 mortality rate by economic status for low-income and middle-income countries: a systematic assessment. Lancet Glob Health. 2018;6(5):e535–e547.
  • Wagstaff A, Bredenkamp C, Buisman LR. Progress on global health goals: are the poor being left behind? World Bank Res Obser. 2014;29(2):137–162.
  • Zere E, Moeti M, Kirigia J, et al. Equity in health and healthcare in Malawi: analysis of trends. BMC Public Health. 2007;7(78). DOI:https://doi.org/10.1186/1471-2458-7-78
  • Umuhoza SM, Ataguba JE. Inequalities in health and health risk factors in the Southern African Development Community: evidence from World Health Surveys. Int J Equity Health. 2018;17(1):52.
  • Hosseinpoor AR, Bergen N, Kunst A, et al. Socioeconomic inequalities in risk factors for non communicable diseases in low-income and middle-income countries: results from the World Health Survey. BMC Public Health. 2012;12:912.
  • Gattini C. Implementing national health observatories: operational approach and strategic recommendations. Implementing National Health Observatories: operational approach and strategic recommendations. 2009.
  • Rezal RS, Hassali MA, Alrasheedy AA, et al. Prescribing patterns for upper respiratory tract infections: a prescription-review of primary care practice in Kedah, Malaysia, and the implications. Expert Rev Anti Infect Ther. 2015;13(12):1547–1556.
  • Ewen M, Joosse HJ, Beran D, et al. Insulin prices, availability and affordability in 13 low-income and middle-income countries. BMJ Glob Health. 2019;4(3):e001410.
  • Godman B, Basu D, Pillay Y, et al. Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future. Hosp Pract (1995). 2020;48(2):51–67.
  • Godman B, Basu D, Pillay Y, et al. Review of ongoing activities and challenges to improve the care of patients with type 2 diabetes across Africa and the implications for the future. Front Pharmacol. 2020;11(108). DOI:https://doi.org/10.3389/fphar.2020.00108
  • Bosch-Capblanch X, Lavis JN, Lewin S, et al. Guidance for evidence-informed policies about health systems: rationale for and challenges of guidance development. PLoS Med. 2012;9(3):e1001185.
  • World Health Organisation. Rio political declaration on social determinants of health. (Ed.^(Eds). World Conference on Social Determinants of Health. Rio de Janeiro, Brazil; 2011 Oct 19–21.
  • Drummond MF, Sculpher MJ, Torrance GW, et al. Methods for the economic evaluation of health care programmes. Oxford (UK): Oxford University Press; 2005.
  • Verguet S, Laxminarayan R, Jamison DT. Universal public finance of tuberculosis treatment in India: an extended cost-effectiveness analysis. Health Econ. 2015;24(3):318–332.
  • Asaria M, Griffin S, Cookson R, et al. Distributional cost-effectiveness analysis of health care programmes--a methodological case study of the UK bowel cancer screening programme. Health Econ. 2015;24(6):742–754.
  • Dawkins BR, Mirelman AJ, Asaria M, et al. Distributional cost-effectiveness analysis in low- and middle-income countries: illustrative example of rotavirus vaccination in Ethiopia. Health Policy Plan. 2018;33(3):456–463.
  • Arnold M, Nkhoma D, Griffin S. Distributional impact of the Malawian essential health package. Health Policy Plan. 2020;35(6):646–656.
  • Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
  • Low- and middle-income countries. [cited 2021 Jun 20]. Available from: https://wellcome.org/grant-funding/guidance/low-and-middle-income-countries
  • Husereau D, Drummond M, Petrou S, et al. Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR health economic evaluation publication guidelines good reporting practices task force. Value Health. 2013;16(2):231–250.
  • Welch V, Petticrew M, Tugwell P, et al. PRISMA-equity 2012 extension: reporting guidelines for systematic reviews with a focus on health equity. PLoS Med. 2012;9(10):e1001333.
  • Tugwell P, Petticrew M, Kristjansson E, et al. Assessing equity in systematic reviews: realising the recommendations of the commission on social determinants of health. BMJ. 2010;341:c4739.
  • Hutton DW, So SK, Brandeau ML. Cost-effectiveness of nationwide hepatitis B catch-up vaccination among children and adolescents in China. Hepatology. 2010;51(2):405–414.
  • Love-Koh J, Mirelman A, Suhrcke M. Equity and economic evaluation of system-level health interventions: a case study of Brazil’s family health program. Health Policy Plan. 2020.
  • Olsen M, Norheim OF, Memirie ST. Reducing regional health inequality: a sub-national distributional cost-effectiveness analysis of community-based treatment of childhood pneumonia in Ethiopia. Int J Equity Health. 2021;20(1):9.
  • Campos NG, Tsu V, Jeronimo J, et al. To expand coverage, or increase frequency: quantifying the tradeoffs between equity and efficiency facing cervical cancer screening programs in low-resource settings. Int J Cancer. 2017;140(6):1293–1305.
  • Hangoma P, Bulawayo M, Chewe M, et al. The potential health and revenue effects of a tax on sugar sweetened beverages in Zambia. BMJ Glob Health. 2020;5(4). DOI:https://doi.org/10.1136/bmjgh-2019-001968
  • Chang AY, Riumallo-Herl C, Perales NA, et al. The equity impact vaccines May have on averting deaths and medical impoverishment in developing countries. Health Aff (Millwood). 2018;37(2):316–324.
  • Rheingans R, Anderson J, Anderson B, et al. Estimated impact and cost-effectiveness of rotavirus vaccination in India: effects of geographic and economic disparities. Vaccine. 2014;32(Suppl 1):A140–150.
  • Rheingans R, Anderson J, Bagamian KH, et al. Effects of geographic and economic heterogeneity on the burden of rotavirus diarrhea and the impact and cost-effectiveness of vaccination in Pakistan. Vaccine. 2018;36(51):7780–7789.
  • Rheingans R, Anderson J, Bagamian KH, et al. Effects of geographic and economic heterogeneity on rotavirus diarrhea burden and vaccination impact and cost-effectiveness in the Lao People’s Democratic Republic. Vaccine. 2018;36(51):7868–7877.
  • Asaria M, Griffin S, Cookson R. Distributional cost-effectiveness analysis: a tutorial. Med Decis Making. 2016;36(1):8–19.
  • Abbas K, Procter SR, van Zandvoort K, et al. Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit-risk analysis of health benefits versus excess risk of SARS-CoV-2 infection. Lancet Glob Health. 2020;8(10):e1264–e1272.
  • Wittenberg M, Leibbrandt M. Measuring inequality by asset indices: a general approach with application to South Africa. Rev Income Wealth. 2017;63(4):706–730.
  • Ucar B. The usability of asset index as an indicator of household economic status in Turkey: comparison with expenditure and income data. Social Indic Res. 2015;121(3):745–760.
  • Øvensen G. An asset index for the Syrian 2003 unemployment survey. (Ed.^(Eds). Fafopaper. 2006.
  • Rutstein SO, Johnson K. The DHS wealth index. DHS comparative reports no. 6. Calverton: ORC Macro; 2004.
  • English indices of deprivation. 2019. [cited 2021 Jun 20]. Available from: https://www.gov.uk/government/statistics/english-indices-of-deprivation-2019
  • Yang F, Angus C, Duarte A, et al. Impact of socioeconomic differences on distributional cost-effectiveness analysis. Med Decis Making. 2020;40(5):606–618.